Protagonist Therapeutics Inc. (PTGX): Billionaire Tom Steyer Likes Upside Potential of This Stock

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has been a accordant diagnostic successful the 13F portfolio of Farallon Capital since the 4th fourth of 2017. Back then, this presumption comprised 900,000 shares. In the quarters since then, the money has steadily built up this stake. Filings for the 4th fourth of 2025 amusement that the money owned 6.1 cardinal shares successful the firm, astir the aforesaid arsenic successful the 3rd 4th of 2025. The steadfast operates arsenic a find and improvement institution successful the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the attraction of adults and pediatric patients 12 years of property and older with moderate-to-severe plaque psoriasis, and Rusfertide, a first-in-class investigational injectable mimetic of the earthy hormone hepcidin successful Phase 3 improvement for the attraction of the uncommon humor upset polycythemia vera.

READ ALSO: 15 Safe Stocks to Invest In For Beginners.

Protagonist Therapeutics, Inc. (NASDAQ:PTGX) has been attracting involvement from elite investors due to the fact that of the caller FDA support and commercialized motorboat of Icotyde for moderate-to-severe plaque psoriasis. Hedge funds presumption Icotyde arsenic a large menace to existent injectable biologics. It is the lone once-daily oral IL-23R peptide connected the market, offering the convenience of a pill with the potency typically reserved for shots. Because the cause was developed with Johnson & Johnson, J&J handles the monolithic planetary selling effort. This allows Protagonist to cod high-margin royalties without the overhead of a income force. The support triggered a $50 cardinal milestone outgo this quarter, with the institution eligible for different $580 cardinal successful aboriginal regulatory and income milestones.

While we admit the imaginable of PTGX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 14 Best Defensive Stocks to Invest In Now and 14 Best Low Risk High Growth Stocks to Buy Right Now.

Disclosure: None. Follow Insider Monkey connected Google News.